Abstract
Aim: This retrospective/prospective observational study was conducted (May 2016-August 2017) to gain insight into the current management of elevated LDL-C in high-risk (HR) and very high-risk (VHR) patients in central/eastern Europe, since information from this region is presently limited.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have